The role of ABCA7 in Alzheimer ’s disease: evidence from genomics, transcriptomics and methylomics

In conclusion, human-based –omics studies provide converging evidence of (partial) ABCA7 loss as an AD pathomechanism, and future studies should make clear if interventions onABCA7 expression can serve as a valuable therapeutic target for AD.
Source: Acta Neuropathologica - Category: Neurology Source Type: research